Santa Cruz Biotechnology features a diverse variety of FAM107 Antibodies for research focused on understanding FAM107 protein functions. FAM107 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). FAM107 plays essential roles in cellular processes such as cell proliferation and differentiation, making it a significant focus in cancer research and developmental biology. Understanding FAM107's regulation of signaling pathways can reveal crucial insights into disease mechanisms and potential therapeutic approaches. FAM107 expression patterns and interactions contribute valuable information about cellular development and disease progression. Researchers investigating FAM107 can uncover new pathways involved in tumorigenesis and other pathological conditions. Advanced detection methods allow for precise visualization and quantification of FAM107 in various cellular compartments. Ongoing studies of FAM107 continue to reveal new functions in both normal physiology and disease states. Santa Cruz Biotechnology monoclonal antibodies for FAM107 enable researchers worldwide to advance scientific understanding of cellular regulation and disease mechanisms.